[HTML][HTML] Evolutionary pressure against MHC class II binding cancer mutations
The anti-cancer immune response against mutated peptides of potential immunological
relevance (neoantigens) is primarily attributed to MHC-I-restricted cytotoxic CD8+ T cell …
relevance (neoantigens) is primarily attributed to MHC-I-restricted cytotoxic CD8+ T cell …
Evolutionary Pressure against MHC Class II Binding Cancer Mutations
RM Pyke, WK Thompson, RM Salem, J Font-Burgada… - Cell, 1991 - academia.edu
(Cell 175, 416–428. e1–e13; October 4, 2018) In the original version of the paper, Dr. Joan
Font-Burgada, who developed the original concept upon which this manuscript was built …
Font-Burgada, who developed the original concept upon which this manuscript was built …
[引用][C] Evolutionary Pressure against MHC Class II Binding Cancer Mutations
RM Pyke, WK Thompson, RM Salem, J Font-Burgada… - Cell, 2018 - cir.nii.ac.jp
Evolutionary Pressure against MHC Class II Binding Cancer Mutations.
R Marty Pyke, WK Thompson, RM Salem… - Cell, 2018 - escholarship.org
The anti-cancer immune response against mutated peptides of potential immunological
relevance (neoantigens) is primarily attributed to MHC-I-restricted cytotoxic CD8+ T cell …
relevance (neoantigens) is primarily attributed to MHC-I-restricted cytotoxic CD8+ T cell …
Evolutionary Pressure against MHC Class II Binding Cancer Mutations.
WK Thompson, RM Salem, J Font-Burgada, M Zanetti… - Cell, 2018 - europepmc.org
The anti-cancer immune response against mutated peptides of potential immunological
relevance (neoantigens) is primarily attributed to MHC-I-restricted cytotoxic CD8+ T-cell …
relevance (neoantigens) is primarily attributed to MHC-I-restricted cytotoxic CD8+ T-cell …
Evolutionary Pressure against MHC Class II Binding Cancer Mutations
RM Pyke, WK Thompson, RM Salem, J Font-Burgada… - Cell, 2018 - cell.com
(Cell 175, 416–428. e1–e13; October 4, 2018) In the original version of the paper, Dr. Joan
Font-Burgada, who developed the original concept upon which this manuscript was built …
Font-Burgada, who developed the original concept upon which this manuscript was built …
[HTML][HTML] Evolutionary Pressure against MHC Class II Binding Cancer Mutations
RM Pyke, WK Thompson, RM Salem, J Font-Burgada… - Cell, 2018 - Elsevier
The anti-cancer immune response against mutated peptides of potential immunological
relevance (neoantigens) is primarily attributed to MHC-I-restricted cytotoxic CD8+ T cell …
relevance (neoantigens) is primarily attributed to MHC-I-restricted cytotoxic CD8+ T cell …
Evolutionary Pressure against MHC Class II Binding Cancer Mutations
RM Pyke, WK Thompson, RM Salem… - Cell, 2018 - pubmed.ncbi.nlm.nih.gov
The anti-cancer immune response against mutated peptides of potential immunological
relevance (neoantigens) is primarily attributed to MHC-I-restricted cytotoxic CD8+ T cell …
relevance (neoantigens) is primarily attributed to MHC-I-restricted cytotoxic CD8+ T cell …
[HTML][HTML] Evolutionary pressure against MHC class II binding cancer mutations
RM Pyke, WK Thompson, RM Salem, J Font-Burgada… - Cell, 2018 - ncbi.nlm.nih.gov
The anti-cancer immune response against mutated peptides of potential immunological
relevance (neoantigens) is primarily attributed to MHC-I-restricted cytotoxic CD8+ T-cell …
relevance (neoantigens) is primarily attributed to MHC-I-restricted cytotoxic CD8+ T-cell …
Evolutionary pressure against MHC class II binding cancer mutations
RM Pyke, WK Thompson, RM Salem - Cell, 2018 - dialnet.unirioja.es
The anti-cancer immune response against mutated peptides of potential immunological
relevance (neoantigens) is primarily attributed to MHC-I-restricted cytotoxic CD8+ T cell …
relevance (neoantigens) is primarily attributed to MHC-I-restricted cytotoxic CD8+ T cell …